Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Dna X (SONM) Other Non Operating Income (2018 - 2025)

Dna X filings provide 8 years of Other Non Operating Income readings, the most recent being $179000.0 for Q4 2025.

  • On a quarterly basis, Other Non Operating Income fell 60.13% to $179000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$161000.0, a 165.45% decrease, with the full-year FY2025 number at -$161000.0, down 165.45% from a year prior.
  • Other Non Operating Income hit $179000.0 in Q4 2025 for Dna X, up from -$161000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $601000.0 in Q4 2022 to a low of -$215000.0 in Q2 2025.
  • Median Other Non Operating Income over the past 5 years was -$49500.0 (2021), compared with a mean of -$5200.0.
  • Biggest five-year swings in Other Non Operating Income: tumbled 2166.67% in 2021 and later soared 45000.0% in 2024.
  • Dna X's Other Non Operating Income stood at -$40000.0 in 2021, then surged by 1602.5% to $601000.0 in 2022, then crashed by 100.17% to -$1000.0 in 2023, then soared by 45000.0% to $449000.0 in 2024, then crashed by 60.13% to $179000.0 in 2025.
  • The last three reported values for Other Non Operating Income were $179000.0 (Q4 2025), -$161000.0 (Q3 2025), and -$215000.0 (Q2 2025) per Business Quant data.